Naimish Patel, Chief Medical Officer at CRISPR Therapeutics AG (CRSP), sold 3,786 shares at $55.62 ($211K) on 2026-05-29, disclosed to the SEC on 2026-06-01.
Open-market sale of $211k CRSP by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CRSP | SELL | 2025-05-30 | $283K | — | Filing → |